Literature DB >> 2228323

Drug trials on healthy volunteers in Yugoslavia.

R Vrhovac1, I Francetić, K Rotim.   

Abstract

Ninety-seven healthy volunteers who participated in different clinical trials (phases III and IV) in a clinical pharmacology unit were interviewed over the period December 1988-February 1990 using questionnaire method. The aim of the investigation was to analyze the examinees' occupational distribution, the degree of insight in the trials they participated in, their opinion about the remuneration they get and their estimate of the importance or inconveniences of numerous trial elements. Only 39 volunteers (40.2%) were members of medical staff: 17 (17.5%) physicians, 17 (17.5%) medical students and 5 (5.2%) nurses. The volunteers assessed the importance of different elements related to the trial marking them from 1-5. They were more afraid of possible adverse drug reactions (ADR) occurring during the trial (median 3.87) than of those that might occur afterwards (2.94). Significant was their concern about the kind of investigated drug (3.49). "Potential contribution of the trial to the medicine and society" (3.30) and "length of time spent in the laboratory" (3.17) followed. The conduct of clinical trials on healthy volunteers in Yugoslavia and legal regulations are discussed at the end of the paper.

Entities:  

Mesh:

Year:  1990        PMID: 2228323

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  7 in total

Review 1.  More than the money: a review of the literature examining healthy volunteer motivations.

Authors:  Leanne Stunkel; Christine Grady
Journal:  Contemp Clin Trials       Date:  2010-12-10       Impact factor: 2.226

2.  Why healthy subjects volunteer for phase I studies and how they perceive their participation?

Authors:  Luis Almeida; Benedita Azevedo; Teresa Nunes; Manuel Vaz-da-Silva; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

3.  Phase 1 healthy volunteer willingness to participate and enrollment preferences.

Authors:  Stephanie C Chen; Ninet Sinaii; Gabriella Bedarida; Mark A Gregorio; Ezekiel Emanuel; Christine Grady
Journal:  Clin Trials       Date:  2017-08-02       Impact factor: 2.486

4.  The effect of a voucher incentive on a survey response rate in the clinical setting: a quasi-randomized controlled trial.

Authors:  Dawid Pieper; Nina Kotte; Peggy Ober
Journal:  BMC Med Res Methodol       Date:  2018-08-16       Impact factor: 4.615

5.  Factors Influencing Participation Of Healthy Volunteers In Clinical Trials: Findings From A Cross-Sectional Study In Delhi, North India.

Authors:  Rajesh Ranjan; Nidhi Bharal Agarwal; Prem Kapur; Amit Marwah; Rizwana Parveen
Journal:  Patient Prefer Adherence       Date:  2019-11-29       Impact factor: 2.711

6.  Motivations and barriers for healthy participants to participate in herbal remedy clinical trial in Tanzania: A qualitative study based on the theory of planned behaviour.

Authors:  Kamaka R Kassimu; Florence A Milando; Justin J Omolo; Gloria Nyaulingo; Hussein Mbarak; Latipha Mohamed; Ramla Rashid; Saumu Ahmed; Mohammed Rashid; Gumi Abdallah; Thabit Mbaga; Fatuma Issa; Omar Lweno; Neema Balige; Bakari Mwalimu; Ali Hamad; Ally Olotu; Said Jongo; Billy Ngasala; Salim Abdulla
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

7.  Motives for participating in a clinical research trial: a pilot study in Brazil.

Authors:  Solange A Nappo; Giovanna B Iafrate; Zila M Sanchez
Journal:  BMC Public Health       Date:  2013-01-10       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.